For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Source: Thailand Medical News   Dec 26, 2019  5 years ago
Pharma Industry News Roche and Sarepta have signed a legal deal providing Roche exclusive commercial rights to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin), Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD), outside the United States. Under the terms of the deal, Sarepta will receive US$1.15 billion in an upfront payment and an equity investment; up to $1.7 billion ...
Source: Thailand Medical News  Dec 21, 2019  5 years ago
Novartis, the Swiss pharmaceutical company is preparing to give away 100 doses of the world's most expensive drug, which treats a rare childhood disorder, through a special recipient selection process. The pharmaceutical giant announced this week that starting next month, its AveXis unit will begin distributing doses of Zolgensma, a one-time gene treatment for spinal muscular atrophy, also ...
Source: Thailand Medical news  Dec 17, 2019  5 years ago
Pharmaceuticals giant Roche said it had received the necessary approval from competition authorities to acquire US gene-therapy group Spark, after the two companies reached a multibillion-dollar deal earlier this year. Incorporated in 2013, Spark Therapeutics specialises in a new and growing segment of medicine for genetic diseases such as blindness, haemophilia, and neurodegenerative...
Source: Thailand Medical News  Dec 11, 2019  5 years ago
It was announced that AstraZeneca will partner with DeepMatter to improve the productivity and reproducibility of compound synthesis by combining the pharma giant’s automated compound synthesis platform with DeepMatter’s DigitalGlassware™ data collection and structuring technology, through a collaboration whose value was not disclosed. Glasgow based DeepMatter,is a big data and ...
Source: Thailand Medical Newss  Dec 11, 2019  5 years ago
Pharma giant Roche has announced that it is terminating its precision medicine partnership with software developer Syapse later this month, the pharmaceutical and diagnostics giant confirmed Friday. The deal will end Dec. 18, less than two years after it began, a company spokesperson said. Roche spokesperson Patrick Barth told Thailand Medical News,  "As partnerships evolve, prioritie...
Source: Thailand Medical News  Dec 10, 2019  5 years ago
Pharma News The American Regulator,  the Food and Drug Administration (FDA) has approved the first generic versions of Novartis multiple sclerosis drug Gilenya (fingolimod).   Applications for the generic fingolimod by HEC Pharm, Biocon and Sun Pharmaceutical Industries secured the FDA authorisation to treat adults with relapsing forms of multiple sclerosis.   Multiple sclerosis ...
Source: Thailand Medical News  Dec 10, 2019  5 years ago
Pharma News The global HIV specialists pharma company, ViiV Healthcare, majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, has filed a New Drug Application in the US for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV-1 infection. Fostemsavir, the drug is being developed for use in combination with other antiretroviral agents ...
Source: Thailand Medical News  Dec 02, 2019  5 years ago
Many big pharma and biotech conglomerates are going through a tough time. As businesses struggles, significant debt and legal liabilities put some industry players at particularly high risk of declaring bankruptcy in the near future, including large drugmakers like Teva Pharmaceutical and Bausch Health as well as small biotechs including Clovis Oncology and Puma Biotechnology. A pharma industry...
Source: Thailand Medical News  Dec 02, 2019  5 years ago
Biopharmaceutical company Incyte has announced that the US Food and Drug Administration (FDA) accepted for priority review its New Drug Application (NDA) for pemigatinib as a treatment for patients with cholangiocarcinoma.   Typically, Cholangiocarcinoma is cancer that forms in the bile duct, with patients often diagnosed at a late or advanced stage.   The drug Pemigatinib is a selecti...
Source: Thailand Medical News  Nov 27, 2019  5 years ago
Bempedoic acid is an oral, once-daily ATP citrate lyase (ACL) inhibitor that reduces cholesterol synthesis in the liver and is currently undergoing regulatory review Bempedoic acid lowered LDL-Cholesterol by 17% on top of maximally-tolerated statin therapy at 12 weeks, and the effect was durable through 52 weeks1 Overall adverse events in the bempedoic acid treatment arm were comparable to pla...
Source: Thailand Medical News  Nov 26, 2019  5 years ago
Thailand Pharma News Patients with multiple sclerosis often pay, on average, nearly US$7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price of these disease-modifying medications is rising by 10% to 15% each year for the past decade. A team of researchers at Oregon Health & Science University and the...
Source: Thailand Medical News  Nov 17, 2019  5 years ago
A panel of specialists from the US Food and Drug Administration has approved allowing Amarin Corp Plc's fish-oil derived drug, Vascepa to be used as an add-on therapy for reducing the chance of heart attack and stroke in high-risk patients with cardiovascular disease.   Everyone of the 16 panelists voted that the drug should be sold as a medicine to reduce the risk of cardiovascular eve...
Source: Thailand Medical News  Nov 07, 2019  5 years ago
Pharma giant, Biogen has signed a commercialisation agreement with Samsung Bioepis for biosimilar candidates SB11 (ranibizumab) and SB15 (aflibercept).   SB11, referencing Lucentis, is in Phase III clinical trial and SB15, referencing Eylea, is a pre-clinical candidate. The deal will allow Biogen to commercialise the biosimilars in the US, Canada, Europe, Japan and Australia. Lucentis ...

MOST READ

Mar 10, 2025  27 days ago
Nikhil Prasad
Feb 17, 2025  2 months ago
Nikhil Prasad
Dec 11, 2024  4 months ago
Nikhil Prasad
Nov 26, 2024  4 months ago
Nikhil Prasad
Nov 19, 2024  5 months ago
Nikhil Prasad
Nov 12, 2024  5 months ago
Nikhil Prasad
Nov 05, 2024  5 months ago
Nikhil Prasad
Nov 05, 2024  5 months ago
Nikhil Prasad
Jul 25, 2024  8 months ago
Nikhil Prasad

Interesting Reads

Nikhil Prasad
Oct 21, 2024  6 months ago
Nikhil Prasad
Oct 02, 2024  6 months ago
Nikhil Prasad
Jul 24, 2024  9 months ago
Nikhil Prasad
Jul 23, 2024  9 months ago
Nikhil Prasad
Jun 24, 2024  10 months ago
Nikhil Prasad
Jun 22, 2024  10 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Jun 10, 2023  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 04, 2022  3 years ago